Control Group | |||
Variable | Female n = 24 | Male n = 12 | P |
GLS transmural, % | − 22.5 ± 2.4 | − 21.6 ± 1.8 | .235 |
GLS endocardium, % | − 25.6 ± 2.8 | −24.6 ± 2.1 | .284 |
GLS epicardium, % | − 19.9 ± 2.0 | − 19.1 ± 1.6 | .250 |
Coronary Artery Disease Group | |||
Variable | Female n = 11 | Male n = 32 | P |
GLS transmural, % | − 18.5 ± 2.6 | − 18.1 ± 2.4 | .664 |
GLS endocardium, % | − 21.0 ± 3.2 | − 20.8 ± 2.8 | .790 |
GLS epicardium, % | − 15.9 ± 2.9 | − 15.9 ± 2.3 | .949 |